1. Most Discussed
  2. Gainers & Losers
  1. Members, Techs apologise for the loss of thread titles, and are currently working on restoring them. They will be back asap. Thank you
CYP $1.17

Idiots guide to a Cynata punt

  1. philby

    944 Posts.
    Apart from Dr Stewart and Dr Ross behind the scenes we have:

    Dr. Chiplin was founding CEO of Arana Therapeutics, a new generation antibody developer and a board member of Domantis, Inc., prior to the acquisition of these companies by Cephalon ($329 million) and GSK ($458 million), respectively
    (Cynata valuation for acquisition purposes even at $200 mill equals $2.90 with todays shares on issue)

    Dr Kilian Kelly Vice President, Product Development His previous appointments include Senior Director, Drug Development at Biota Pharmaceuticals (NASDAQ: BOTA), Vice President, Regulatory and Clinical at Mesoblast Limited (ASX:MSB), and various regulatory affairs and project management positions with Kendle International (now INC Research), Amgen (NASDAQ: AMGN) and Astrazeneca (LSE: AZN).. He is a registered pharmacist and a member of the Royal Pharmaceutical Society, The Organisation for Professionals in Regulatory Affairs (TOPRA) and the Regulatory Affairs Professionals Society (RAPS).
    Perfect guy for the complicated nuts and bolts of this business!
    Peer analysis straight off the commsec site some with earnings but most without;
    As of 2014 .06..bit out of date but wtf!
    PRR (Roberts new home )..MC 49 mill
    MSB…1.4 bill
    BNO..163 mill
    PBT..86 mill
    BLT..132 mill
    SRX..947 mill
    SPL…153 mill
    CYP…22 mill…as of Friday 26 mill..
    In fact I couldnt find a listed company in the world in the regen space as cheap as Cynata..maybe there is but I didnt find it!
    So with the proviso that some info is positive about Waisman, I’m still on for a dollar in march..at a dollar (68 mill MC) it is still the cheapest in comparison to its peers cos of the relatively few shares on issue.
    If the new story tellers are worth their salt…lots of risk apetite investors are gonna know all this and a lot more soon.
    Buy hey check it out yourselves cos im just a dumbxxxx!!!!..Thats why Im buying?

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.